Live Breaking News & Updates on Mind Medicine Mindmed Inc

Stay updated with breaking news from Mind medicine mindmed inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MindMed to Participate in the Cantor Fitzgerald Neurology & Psychiatry Conference

/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing. ....

United States , San Francisco , Ritz Carlton , Panel Time , Panel Title , Prnewswire Mind Medicine Mindmed Inc , Company Or Mindmed , Medicine Mindmed Inc , Cantor Fitzgerald Neurology , Psychiatry Conference , Mind Medicine Mindmed Inc ,

MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA

/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing. ....

Miri Halperin Wernli , Exchange Commission , Company Annual Report On Form , Prnewswire Mind Medicine Mindmed Inc , Company Or Mindmed , Matthias Liechti At University Hospital Basel , Medicine Mindmed Inc , Matthias Liechti , University Hospital Basel , Executive President , Visual Analog Scales , Altered States , Annual Report , Quarterly Reports , Note Regarding Forward Looking Statements , Financial Condition , Mind Medicine Mindmed Inc ,

MindMed Announces Pricing of Public Offering of Common Shares and Warrants

/PRNewswire/ Mind Medicine (MindMed) Inc. ("MindMed") (NASDAQ: MNMD) (NEO: MMED), a clinical stage biopharmaceutical company developing novel products to. ....

New York , United States , Exchange Commission , Cantor Fitzgerald Co , Prnewswire Mind Medicine Mindmed Inc , Oppenheimer Co , Equity Capital Markets , Cantor Fitzgerald , Capital Markets , Annual Report , Quarterly Report , Note Regarding Forward Looking Statements , Financial Condition , Mind Medicine Mindmed Inc ,

MindMed Announces Proposed Public Offering of Common Shares

/PRNewswire/ Mind Medicine (MindMed) Inc. ("MindMed") (Nasdaq: MNMD) (NEO: MMED), a clinical stage biopharmaceutical company developing novel products to. ....

New York , United States , Exchange Commission , Cantor Fitzgerald Co , Prnewswire Mind Medicine Mindmed Inc , Oppenheimer Co , Equity Capital Markets , Cantor Fitzgerald , Capital Markets , Annual Report , Quarterly Report , Note Regarding Forward Looking Statements , Financial Condition , Mind Medicine Mindmed Inc ,

MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances

/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing. ....

Matthias Liechti , Miri Halperin Wernli , Exchange Commission , Company Annual Report On Form , Prnewswire Mind Medicine Mindmed Inc , Company Or Mindmed , Matthias Liechti At University Hospital Basel , Leichti Lab , University Hospital Basel , Executive President , Visual Analog Scales , Annual Report , Quarterly Reports , Note Regarding Forward Looking Statements , Financial Condition , Mind Medicine Mindmed Inc ,